THERADIAG Selected as a Partner of the ABIRISK Project, the First Consortium of Pharmaceutical and
Regulatory News: Theradiag (Paris:ALTER) (ISIN: FR0004197747, Ticker: ALTER), a company specializing in theranostics and in vitro diagnostics, is proud to …